首页> 外文期刊>Proceedings >Predicting Recurrence after a First Unprovoked Venous Thromboembolism: Retrospective Validation of the DAMOVES Score
【24h】

Predicting Recurrence after a First Unprovoked Venous Thromboembolism: Retrospective Validation of the DAMOVES Score

机译:首次无缘静脉血栓栓塞后的复发预测:DAMOVES评分的回顾性验证

获取原文
           

摘要

Unprovoked venous thromboembolism is associated with a 5 to 27% annual risk of recurrence after discontinuation of anticoagulation, and indefinite anticoagulation is recommended if the bleeding risk is low to moderate. However, in one-third of patients with unprovoked venous thromboembolism, the risk of recurrence is so low (&5% per year) that anticoagulant therapy &3a??6 months may not be necessary. Several prediction rules were derived to identify patients with unprovoked venous thromboembolism who have a low recurrence risk. In 2016, we presented our results of the original DAMOVES, a nomogram for prediction of recurrence in an individual patient with unprovoked venous thromboembolism. The aim of this study was to externally validate this nomogram in patients with unprovoked venous thromboembolism.
机译:无缘无故的静脉血栓栓塞与中止抗凝治疗后每年5至27%的复发风险相关,如果出血风险低至中度,建议无限期抗凝治疗。但是,在三分之一的无缘无故的静脉血栓栓塞患者中,复发的风险非常低(每年<5%),以至于抗凝治疗≥3a-6个月可能是不必要的。推导了一些预测规则,以鉴定具有低复发风险的无因静脉血栓栓塞的患者。在2016年,我们介绍了原始DAMOVES的结果,该图是诺模图,用于预测无缘静脉血栓栓塞患者的复发情况。这项研究的目的是从外部验证无端静脉血栓栓塞患者的诺模图。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号